If you dont see results after reaching an adequate dose with proper adherence, talk to your provider about alternatives switching to weekly injection, adding the Precision Peptide Genetic Test for a GLP1R/GIPR baseline, or escalating to a dual-agonist option like PlexusDx GLP-Squared
New JAMA Study Links Wegovy to NAION A JAMA study published on July 3, 2024, on the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide found an increased risk of the condition in patients taking semaglutide compared to those taking non-GLP-1 RA medications
Ascorbic acid and the catabolism of cholesterol
Robert Popovian 18:11 And if you have any questions, thoughts, suggestions, comments, any thoughts about any future policy issues you want to hear from both Ben and I, from Vibhu or Conrad
Home storage is also therefore simplified
625 NRD.E1 is a novel non-opioid therapeutic that is being developed for the treatment of PDPN
